Impact of digital assistive technologies on the quality of life for people with dementia: protocol for a scoping review Authors: Charlotte Schneider, Tobias Kowatsch, Rasita Vinay Published: 2023 ABSTRACT AbstractIntroductionDigital assistive technologies (eg, applications, wearables and robots) have emerged as promising tools for managing various aspects of daily life, such as basic assistance, encompassing social interaction, memory support, leisure activities, location tracking and health monitoring. In order to understand how these technologies can be utilised for people living with dementia, their impacts must first be reviewed. Currently, there is limited literature available on the topic, usually only focusing on a particular kind of digital assistive technology. Therefore, this paper presents a protocol for a scoping review that aims to provide a general overview of the impact digital assistive technologies can have on the quality of life for people living with dementia.Methods and analysisWe will follow the scoping review framework proposed by Arksey and O'Malley. A comprehensive search will be performed to identify original research articles or clinical trials published between 2013 and 2023 across five online databases (Cochrane, Embase, PubMed, Scopus and Web of Science). The review will encompass both qualitative and quantitative themes derived from the literature. Relevant studies will be identified through a comprehensive search using specific search terms related to the population (people with dementia), intervention (digital assistive technologies) and outcome (quality of life). The screening of titles, abstracts and full texts will be performed to select eligible studies based on predetermined inclusion and exclusion criteria. Data will be extracted using a standardised form, and the findings will be synthesised and reported qualitatively and quantitatively.Ethics and disseminationEthical approval is not required because this study is a scoping review based on published data. We intend to publish our findings in a peer-reviewed journal.Keywords: Dementia, Quality of life, Ageing, Information technology, Patient-centred care, Public health STRENGTHS AND LIMITATIONS OF THIS STUDY This scoping review represents the first attempt to provide a comprehensive overview of digital assistive technologies and their impact on quality of life for people with dementia. This scoping review represents the first attempt to provide a comprehensive overview of digital assistive technologies and their impact on quality of life for people with dementia. An extensive search strategy will be implemented, covering five electronic databases, spanning a period of 10 years. An extensive search strategy will be implemented, covering five electronic databases, spanning a period of 10 years. However, given the rapidly expanding field of digital health technologies, it is possible that this scoping review may overlook ongoing or planned studies. However, given the rapidly expanding field of digital health technologies, it is possible that this scoping review may overlook ongoing or planned studies. Introduction In 2023, more than 55 million individuals worldwide are affected by dementia with 60% of this population living in low-income and middle-income countries.1 Dementia encompasses various impairments regarding memory, cognition and the ability to perform daily activities.1 It progressively worsens over time and primarily affects older individuals (over the age of 65), although not everyone will experience it. There are also possibilities for individuals younger than 65 years of age to develop dementia, known as young onset dementia. Globally, dementia currently ranks as the seventh leading cause of death, significantly contributing to disability and dependency among the older population.1 This demographic shift poses challenges for caregivers and our healthcare system, prompting increased attention towards mitigating these burdens through digital assistive technologies to sustain the independence of people with dementia (PWD).2 Digital assistive technologies can help individuals and caregivers manage aspects of their daily lives. They are promising tools for the care and support of elderly people and also help to ease the burdens of caregiving. Advancements in technology have led to the development of devices and applications that use sensory data specifically for PWD. For instance, smartphones and wearables are being utilised to monitor physical activities, enabling home care assistance3 or as location trackers to monitor wandering behaviour.4 Furthermore, with the rise of artificial intelligence (AI), there have been developments of smart assistive robots, which can assist PWD by providing companionship and engaging in pet therapy, for example, as demonstrated by the robotic seal, Paro.5 These technologies go beyond mere assistance in daily activities, as they also aid in maintaining social interaction, memory support, participation in leisure activities, location tracking and health monitoring.2 6 To this end, maintaining a good quality of life is essential for PWD and must be considered when assessing the impact of digital assistive technologies. Quality of life encompasses physical and mental health, as well as social and emotional well-being (eg, emotional stability, social integration or self-esteem).7 Quality of life can be measured with different instruments, such as questionnaires and self-rating scales for the individual’s overall perceived quality of life, and also through activity instruments or cognitive status assessments.8 These measures and instruments must therefore also be considered as guiding tools for determining the quality of life for PWD. This scoping review aims to provide a general overview of the impact digital assistive technologies can have on the quality of life for PWD, due to the lack of existing literature reviews on the topic. Through this scoping review, we hope to explore the opportunities and potential benefits that digital technology can offer in improving caregiving and living standards of PWD. Furthermore, this review serves as a tool to create greater awareness among various stakeholders, including policymakers, researchers, politicians and even management teams of elderly care companies and institutions. By presenting a synthesis of current evidence, it can strengthen the decision-making process by enabling stakeholders to understand what digital assistive technologies are available and what works effectively in enhancing the quality of life as a goal of care. Methodology Scoping review We will use the framework proposed by Arksey and O’Malley for this review.9 Therefore, the scoping review will follow the following five-step process: (1) identifying the research question, (2) identifying relevant studies, (3) selecting eligible studies, (4) charting the data and (5) collating and summarising the results. We will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR).10 As the main aim of this scoping review is to describe the state of the literature, a quality assessment will not be conducted as generally done for a systematic review. This scoping review has been preregistered on OSF Registries (https://osf.io/zcnx8/). Identifying the research question The main research question this review aims to answer is, ‘what is the impact of digital assistive technologies on the quality of life for PWD?’. The findings will present both qualitative and quantitative themes surrounding the research question, providing a current overview of the impact of digital assistive technologies on the quality of life for PWD, as reflected in the literature. The research question was formulated using the population, intervention and outcome (PIO) concept (see table 1) according to prior work.11 Table 1The PIO framework for the eligibility of studiesConceptDeterminantsP = populationPeople with dementiaI = interventionDigital assistive technologiesO = outcomeQuality of life The PIO framework for the eligibility of studies Identifying relevant studies The search terms and strategy used in this scoping review are summarised in table 2 for each PIO concept. Search terms were derived from a preliminary search and analysed by comparing the words found in titles, abstracts and keywords. Additionally, to enhance the accuracy and comprehensiveness of the search results, all authors were involved in a consensus process, and an additional expert was consulted to validate the identified terms and suggest any additional relevant keywords. Table 2The search terms derived for the PIO frameworkConceptTerms1: People with dementiaalzheimer* OR dement* OR early-onset OR frontotemporal lobar degeneration OR lewy-body dementia OR mixed dementias OR vascular dementia OR young onset2: Digital assistive technologiesdigital assistive tool* OR digital assistive technolog* OR gerontechnolog* OR mobile OR robot* OR supportive technolog* OR technolog* assistive device* OR voice assistant* OR wearable device* OR wearable technolog*3: Quality of lifeactivities of daily living OR independence OR life quality OR living standards OR mental health OR perception OR physical health OR satisfaction OR quality of life OR qol OR safety OR standard of living OR value of life OR well-being The search terms derived for the PIO framework A comprehensive search will be performed across five electronic databases (Cochrane, Embase, PubMed, Scopus and Web of Science), to locate published literature surrounding the research question. The search strategy exclusively considers articles published between 2013 and 2023 to focus on recent technological advancements, allowing for a more up-to-date review. Authors CS and RV also conducted searches on IEEE Xplore and ACM Digital Library to represent technology and engineering databases; however, it was determined that they were mostly duplicate results of those already found using healthcare databases or were largely irrelevant. The terms from table 2 are applied to each database, scanning for the title, abstract and, if available, Medical Subject Headings terms; otherwise, keywords. The Boolean operator OR is utilised within each concept, and each concept is then linked together using the AND operator. Selection of eligible studies The screening of titles and abstracts will be guided by the PIO framework (see table 1), following the eligibility criteria in table 3 to ensure the relevance of the included studies to the research question. Table 3Inclusion and exclusion criteriaInclusion criteriaExclusion criteria Original Research Articles or Clinical Trials (completed)Articles which have a primary focus on digital assistive technologies for PWDArticles discussing perspectives of caregivers, family members or healthcare workers in relation to a PWDArticles about people living in diverse settings including communities, hospitals or nursing homes and all severities of dementia. We will not use age as a criterion. Articles not in English or GermanArticles which discuss dementia negligibly or with other comorbidities/health conditionsArticles that mention digital assistive technologies briefly or as an insignificant part of a reviewPilot or feasibility studies which only report the implementation of an interventionBook chapters, commentaries, conference proceedings, editorials, interviews, opinion pieces, proposals, reports, protocols, short newsNon-human studies PWD, people with dementia. Inclusion and exclusion criteria Original Research Articles or Clinical Trials (completed) Original Research Articles or Clinical Trials (completed) Articles which have a primary focus on digital assistive technologies for PWD Articles which have a primary focus on digital assistive technologies for PWD Articles discussing perspectives of caregivers, family members or healthcare workers in relation to a PWD Articles discussing perspectives of caregivers, family members or healthcare workers in relation to a PWD Articles about people living in diverse settings including communities, hospitals or nursing homes and all severities of dementia. We will not use age as a criterion. Articles about people living in diverse settings including communities, hospitals or nursing homes and all severities of dementia. We will not use age as a criterion. Articles not in English or German Articles not in English or German Articles which discuss dementia negligibly or with other comorbidities/health conditions Articles which discuss dementia negligibly or with other comorbidities/health conditions Articles that mention digital assistive technologies briefly or as an insignificant part of a review Articles that mention digital assistive technologies briefly or as an insignificant part of a review Pilot or feasibility studies which only report the implementation of an intervention Pilot or feasibility studies which only report the implementation of an intervention Book chapters, commentaries, conference proceedings, editorials, interviews, opinion pieces, proposals, reports, protocols, short news Book chapters, commentaries, conference proceedings, editorials, interviews, opinion pieces, proposals, reports, protocols, short news Non-human studies Non-human studies PWD, people with dementia. On 17 May 2023, a literature search was conducted across the electronic databases previously mentioned, resulting in 5027 articles and trials (see online supplemental file 1). The search results were extracted and uploaded onto a literature review software, Rayyan (https://www.rayyan.ai) for screening (see figure 1 for the screening process). Rayyan is an AI-powered tool for literature and systematic literature reviews, enabling easier collaboration between reviewers. From May to July 2023, authors CS and RV conducted title and abstract screening of all eligible articles to determine their suitability for a full-text review according to the inclusion and exclusion criteria. Author TK was involved when substantial discrepancies were not resolved through discussion and consensus. The level of agreement between the reviewers was calculated and reported. To ensure reliability, authors CS and RV conducted a full-text review to determine their inclusion in the study. Author CS critically analysed the final sample of studies, and all authors were involved in the charting process. PRISMA flow chart. bmjopen-2023-077017supp001.pdf The selection process will follow the recommendations in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR) checklist.10 Charting the data A data extraction form will be used to capture relevant information from each included article. The data charting was done manually in July 2023. An example of the data extraction form is described in table 4. Table 4Data charting formTitle of studyDOIYear of publicationAuthor name(s)Author location(s)Study approachie, qualitative or quantitative or mixed methodType of articleie, Case Study, Observational Study, RCT, Review, Trial, Other…Study locationie, where the study was carried outClass of digital assistive technologyie, AI, Application, AR/VR, Conversational Agent, Wearable, Other…Explanation of the digital assistive technologyie, specification of the digital assistive technology (eg, name/brand)Sensory distribution channelie, acoustic, proprioceptive, tactile, visualTarget populationOutcome measuredie, the primary outcome being measured in the studyAim(s) of the studyStudy methods summaryKey findingsie, study findings relevant to study objectivesQuality of life measureie, how is quality of life measured (eg, rating of quality of life through a questionnaire, activity instrument and cognitive status)Reported effectNotesAI, Artificial Intelligence; AR, Augmented Reality; RCT, Randomised Controlled Trial; VR, Virtual Reality. Data charting form AI, Artificial Intelligence; AR, Augmented Reality; RCT, Randomised Controlled Trial; VR, Virtual Reality. Collating, summarising and reporting the results After conducting full-text reviews using table 4, a final list of studies for the scoping review was constructed in August. These articles were critically analysed, and the main findings were reported in a narrative synthesis accompanied with frequency analysis to present findings on (1) author locations, (2) study approach, (3) type of article, (4) study locations, (5) class of digital assistive technology, (6) sensory distribution channel, (7) target population, (8) outcome being measured and (9) instrument measuring quality of life. From a pilot study of the articles, it can be seen that there is rarely a specific ‘quality of life instrument’ being used. Indirect outcomes, which also influence the quality of life, are therefore recorded (eg, activity instruments, cognitive status and rating of the patient’s quality of life8). Qualitative analysis will help identify the impact of the digital assistive interventions on the target population in each study, providing a holistic overview of quality of life dimensions across all stages of dementia. Therefore, it will be crucial for article eligibility that included studies provide a before and after comparison of quality of life measures or indirect outcomes in order to successfully answer the research question of this scoping review. Patient and public involvement None. Discussion The proposed scoping review aims to demonstrate the impact digital assistive technologies can have on the quality of life for PWD. Through this review, we hope to create greater awareness of the different digital assistive technologies that have been researched, not only for PWD but also their carers. Ultimately, the outcomes of this review will provide evidence-based insights to health policymakers and stakeholders, enabling them to address the pressing needs of an increasingly affected population. The findings will contribute to shaping policies, resource allocation and interventions that effectively leverage digital technologies to improve the quality of care and support available to PWD and their caregivers. A limitation of this review is that certain digital technologies may be missing due to the search terms selected, as there is no uniform definition of ‘digital assistive technologies’. Another limitation is the lack of a market analysis to provide an outlook of companies which already provide digital assistive technologies to individuals with a cognitive impairment, such as those with dementia, and is therefore recommended for future research. Moreover, due to the absence of a quality appraisal, it is not possible to make any remarks regarding the reliability of the study interventions on the measured outcome. A risk of bias of the evidence or methodological limitations was also not assessed, given the focus of the scoping review. Supplementary Material Reviewer comments Author's manuscript Acknowledgments The authors would like to thank Dr Mathias Schlögl for his valuable input and feedback throughout the process. Footnotes Contributors: All authors have made substantial intellectual contributions to the development of this protocol and its revisions. The search question was conceptualised by TK and RV and further developed by CS. The review approach and design were conceptualised by RV, with advice from TK. CS and RV developed and tested search terms with input and revisions from TK. CS initiated drafting of the manuscript followed by further iterations after substantial input and appraisal from TK and RV. All authors approved the final version of the manuscript. Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors. Competing interests: TK is affiliated with the Centre for Digital Health Interventions (CDHI), a joint initiative of the Institute for Implementation Science in Health Care, University of Zurich; the Department of Management, Technology and Economics at ETH Zurich; and the Institute of Technology Management and School of Medicine at the University of St. Gallen. CDHI is funded in part by CSS, a Swiss health insurer. TK is also a cofounder of Pathmate Technologies, a university spin-off company that creates and delivers digital clinical pathways. However, neither CSS nor Pathmate Technologies was involved in this research. All other authors declare no conflict of interest. Patient and public involvement: Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research. Provenance and peer review: Not commissioned; externally peer reviewed. Supplemental material: This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise. Ethics statements Patient consent for publication Not applicable. References Associated Data Supplementary Materials bmjopen-2023-077017supp001.pdf Reviewer comments Author's manuscript